We are live on ! Find out more
GT

Glenview Trust Portfolio holdings

AUM $6.37B
1-Year Est. Return 23.72%
This Fund
S&P 500
This Quarter Est. Return
+6.39%
1 Year Est. Return
+23.72%
3 Year Est. Return
+87.8%
5 Year Est. Return
+115.86%
10 Year Est. Return
AUM
$963M
AUM Growth
Cap. Flow
+$968M
Cap. Flow %
100.6%
Top 10 Hldgs %
22.24%
Holding
253
New
253
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$29.4M
2
IBM icon
IBM
IBM
+$28.7M
3
AAPL icon
Apple
AAPL
+$23.8M
4
XOM icon
ExxonMobil
XOM
+$23.2M
5
JPM icon
JPMorgan Chase
JPM
+$19.6M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 16.07%
2 Healthcare 15.82%
3 Consumer Staples 15.77%
4 Financials 12.52%
5 Industrials 8.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKT icon
251
BlackRock Income Trust
BKT
$331M
$64K 0.01%
+3,333
New +$63.7K
AEG icon
252
Aegon
AEG
$14B
$63K 0.01%
+15,554
New +$66.3K
SIRI icon
253
SiriusXM
SIRI
$10.4B
$49K 0.01%
+1,200
New +$48.5K

Similar funds

Glenview Trust's Q4 2015 Portfolio in Review

Q4 2015 is the first quarter with a 13F filing on record for Glenview Trust, which disclosed 253 positions worth $963M. Its ten largest holdings account for 22% of the portfolio.

Its largest position is Procter & Gamble: 385,247 shares worth $30.6M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, followed by Healthcare and Consumer Staples.

  • Glenview Trust's largest Q4 2015 buy was Procter & Gamble: 385,247 shares worth $30.6M.
  • Glenview Trust's ten largest holdings make up 22% of its $963M portfolio in Q4 2015.
  • Glenview Trust disclosed 253 positions in Q4 2015, its first 13F filing on record.

Based on Glenview Trust's 13F filing for Q4 2015, filed 28 Apr 2017.